Corbus Pharmaceuticals Holdings, Inc.

JPMORGAN CHASE & CO CRBP

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

43,415

Value ($000)

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	5	0.0%	43,415	12/31/2022
2022 Q3	11/14/2022	7	0.0%	43,974	9/30/2022
2022 Q2	8/11/2022	14	0.0%	53,676	6/30/2022
2022 Q1	5/11/2022	55	0.0%	103,145	3/31/2022
2021 Q4	2/11/2022	66	0.0%	107,590	12/31/2021
2021 Q3	11/12/2021	35	0.0%	34,582	9/30/2021
2021 Q2	8/12/2021	342	0.0%	187,252	6/30/2021
2021 Q1	5/12/2021	617	0.0%	312,978	3/31/2021
2020 Q4	2/19/2021	323	0.0%	259,070	12/31/2020
2020 Q3	11/12/2020	61	0.0%	30,841	9/30/2020
2020 Q2	8/11/2020	195	0.0%	23,285	6/30/2020
2020 Q1	5/12/2020	1,233	0.0%	235,353	3/31/2020
2019 Q4	2/11/2020	987	0.0%	180,779	12/31/2019